State of Wisconsin Investment Board’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.25M Buy
96,491
+1,730
+2% +$137K 0.02% 829
2025
Q4
$7.5M Sell
94,761
-2,076
-2% -$156K 0.02% 824
2025
Q3
$6.34M Buy
96,837
+143
+0.1% +$6.98K 0.01% 859
2025
Q2
$3.82M Sell
96,694
-11,622
-11% -$380K 0.01% 1028
2025
Q1
$3.27M Buy
108,316
+7,085
+7% +$232K 0.01% 1071
2024
Q4
$3.54M Buy
101,231
+15,065
+17% +$563K 0.01% 1084
2024
Q3
$3.45M Sell
86,166
-1,534
-2% -$71.4K 0.01% 1103
2024
Q2
$4.18M Sell
87,700
-4,115
-4% -$169K 0.01% 1003
2024
Q1
$3.98M Sell
91,815
-11,750
-11% -$560K 0.01% 1030
2023
Q4
$5.24M Sell
103,565
-2,200
-2% -$105K 0.01% 958
2023
Q3
$4.8M Sell
105,765
-3,545
-3% -$146K 0.02% 942
2023
Q2
$4.48M Sell
109,310
-5,941
-5% -$228K 0.01% 1013
2023
Q1
$4.12M Sell
115,251
-12,976
-10% -$487K 0.01% 1067
2022
Q4
$4.84M Sell
128,227
-1,627
-1% -$68.4K 0.02% 961
2022
Q3
$5.74M Sell
129,854
-7,379
-5% -$311K 0.02% 861
2022
Q2
$5.08M Buy
137,233
+22,782
+20% +$859K 0.01% 983
2022
Q1
$4.24M Buy
114,451
+97,397
+571% +$3.19M 0.01% 1223
2021
Q4
$519K Sell
17,054
-525
-3% -$16.5K ﹤0.01% 1672
2021
Q3
$590K Buy
17,579
+830
+5% +$31.3K ﹤0.01% 1641
2021
Q2
$668K Sell
16,749
-55,456
-77% -$2.17M ﹤0.01% 1593
2021
Q1
$3.25M Sell
72,205
-27,880
-28% -$1.55M 0.01% 1141
2020
Q4
$5.66M Buy
100,085
+24,349
+32% +$1.21M 0.01% 945
2020
Q3
$3.59M Sell
75,736
-200
-0.3% -$11.1K 0.01% 1034
2020
Q2
$4.48M Buy
75,936
+5,760
+8% +$320K 0.01% 920
2020
Q1
$3.32M Sell
70,176
-17,980
-20% -$1M 0.01% 926
2019
Q4
$5.33M Sell
88,156
-1,547
-2% -$92.2K 0.01% 915
2019
Q3
$5.37M Sell
89,703
-2,999
-3% -$195K 0.01% 806
2019
Q2
$5.96M Buy
92,702
+69,321
+296% +$4.9M 0.02% 777
2019
Q1
$1.9M Sell
23,381
-580
-2% -$37.4K 0.01% 1021
2018
Q4
$1.29M Hold
23,961
﹤0.01% 1062
2018
Q3
$1.24M Sell
23,961
-500
-2% -$23.5K ﹤0.01% 1140
2018
Q2
$1.02M Sell
24,461
-310
-1% -$13.7K ﹤0.01% 1161
2018
Q1
$1.09M Sell
24,771
-573
-2% -$29.1K ﹤0.01% 1105
2017
Q4
$1.27M Buy
25,344
+209
+0.8% +$11.5K ﹤0.01% 1048
2017
Q3
$1.27M Buy
25,135
+519
+2% +$27.2K ﹤0.01% 1032
2017
Q2
$1.25M Buy
24,616
+550
+2% +$25.6K ﹤0.01% 1017
2017
Q1
$967K Sell
24,066
-41,851
-63% -$1.88M ﹤0.01% 1038
2016
Q4
$3.15M Sell
65,917
-11,113
-14% -$440K 0.01% 870
2016
Q3
$2.82M Sell
77,030
-3,000
-4% -$93.9K 0.01% 983
2016
Q2
$1.86M Buy
80,030
+70,030
+700% +$2.26M 0.01% 1112
2016
Q1
$405K Buy
+10,000
New +$406K ﹤0.01% 1281
2015
Q4
Sell
-89,310
Closed -$3.61M 1318
2015
Q3
$3.61M Sell
89,310
-2,590
-3% -$134K 0.01% 897
2015
Q2
$5.29M Buy
+91,900
New +$5.84M 0.02% 816
2014
Q3
Sell
-130,000
Closed -$4.48M 1339
2014
Q2
$4.48M Buy
+130,000
New +$4.09M 0.02% 867

Other funds holding IONS

State of Wisconsin Investment Board's IONS Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Ionis Pharmaceuticals (IONS) stake by 1.8% in Q1 2026, buying an estimated $137K and bringing the position to 96,491 shares worth $7.25M. The position accounts for 0.02% of the portfolio, ranked #829.

State of Wisconsin Investment Board first reported a position in IONS in Q2 2014 and has held it in 44 quarters since. The position peaked at $7.5M in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • State of Wisconsin Investment Board held 96,491 shares of Ionis Pharmaceuticals worth $7.25M as of Q1 2026.
  • State of Wisconsin Investment Board bought 1,730 Ionis Pharmaceuticals shares in Q1 2026, an estimated $137K.
  • Ionis Pharmaceuticals made up 0.02% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #829 holding.
  • State of Wisconsin Investment Board first reported a position in Ionis Pharmaceuticals in Q2 2014 and has held it in 44 quarters since.
  • State of Wisconsin Investment Board's Ionis Pharmaceuticals position peaked at $7.5M in Q4 2025.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.